A priori prediction of activity for HIV-1 protease inhibitors employing energy minimization in the active site
Year: 1995
Type: article
Source: Journal of Medicinal Chemistry
DOI: 10.1021/jm00002a012
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Drug Discovery
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2040086703
